AOD-9604 holds no Health Canada human or veterinary use authorization, and Health Canada has stated in public advisories that unauthorized injectable peptide products are illegal regardless of the 'for research use only' labelling on the container
Complete full cycles before major protocol changes
Oral delivery via PepT1: Published research (Dalmasso et al., 2008, Gastroenterology ) demonstrated that KPV can be absorbed through the PepT1 intestinal peptide transporter, enabling oral administration extremely unusual for a therapeutic peptide
A consult can also sort whether your main driver is collagen loss, pigment, laxity, or a mix
Studies suggest that mechanistic interpretation is strongest when exposure time, formulation state, and control selection are kept constant
IGF-1 LR3 (1mg Vial) Dosage Protocol Long-acting IGF-1 analog studied for anabolic effects research/educational dosing reference